Showing results (121-130 of 324) with videos related to
Sort By:
Pageof 33
Vaccine|February 16, 2011
Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individualsChantale Bernatchez, Kuichin Zhu, Yufeng Li, et al.Melanoma Research|December 21, 2010
Pelvic computed tomography scans for surveillance in patients with primary melanoma in the head and neckGladys C Alvarado, Nicholas E Papadopoulos, Wen-Jen Hwu, et al.Human Gene Therapy|November 13, 2002
Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2Michael H Kershaw, Gang Wang, Jennifer A Westwood, et al.Journal for Immunotherapy of Cancer|January 25, 2017
Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2012
BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competencyDavid S Hong, Luis Vence, Gerald Falchook, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2025
Facts and Hopes: Toward the Next Quantum Leap in MelanomaKeith T Flaherty, Andrew E Aplin, Michael A Davies, et al.Cancer Immunology, Immunotherapy : CII|September 14, 2019
Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signatureEmily Hinchcliff, Cherie Paquette, Jason Roszik, et al.Journal for Immunotherapy of Cancer|September 24, 2016
A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1Marc Uemura, Faisal Fa'ak, Cara Haymaker, et al.Gynecologic Oncology|May 7, 2021
Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancerJeffrey A How, Shrina Patel, Bryan Fellman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2014
Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutationsAmanda D Bucheit, Guo Chen, Alan Siroy, et al.Pageof 33